Arnoud Loof

Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis

Lenny van Bon, Alsya J. Affandi, Jasper Broen et al. · New England Journal of Medicine · 2013 · 449 citations · Full text

SELDI-TOF-MS of saliva: Methodology and pre-treatment effects

Raymond G. Schipper, Arnoud Loof, J. de Groot et al. · Journal of Chromatography B · 2006 · 132 citations

Translational Medicine, Oral Cavity, Pathology +5

Proteomic analysis of plasma identifies the Toll-like receptor agonists S100A8/A9 as a novel possible marker for systemic sclerosis phenotype

L. van Bon, Marta Cossu, Arnoud Loof et al. · Annals of the Rheumatic Diseases · 2014 · 83 citations

Alterations of coagulation and fibrinolysis in patients with angioedema due to C1-inhibitor deficiency

Mark van Geffen, Massimo Cugno, Paul Lap et al. · Clinical & Experimental Immunology · 2011 · 70 citations · Full text

Immunohematology, Heart Failure, Immunology +23

A novel hemostasis assay for the simultaneous measurement of coagulation and fibrinolysis

Mark van Geffen, Arnoud Loof, Paul Lap et al. · Hematology · 2011 · 63 citations

Pathology, Thrombosis, Laboratory Hematology +22